›Publications›Discontinuation of Chromium-51 for clinical use : what are the possible alternatives for radiopharmacies and nuclear medicine departments ? Discontinuation of Chromium-51 for clinical use : what are the possible alternatives for radiopharmacies and nuclear medicine departments ? Auteurs : Dinet J, Le Cloirec J, Becker S, Salles A, Bohn P. Revue : Ann Pharm Fr Année : 2020 Groupe : QuantIF ← Retour aux publications